The US Food and Drug Administration rebuffed a legal challenge from a coalition of blue states over the abortion pill, ...

The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

Women have been drugged by partners to force abortions. And the pill is routinely used to force victims of sex trafficking to ...

Once someone decides they need an abortion, they will go to great lengths to get one because they know it is the right ...

An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A group of 53 biotech leaders is expressing support for mifepristone in a letter to the FDA, urging the agency not to impose new restrictions on its use as an abortion medication and slamming a ...

Journalist Rebecca Grant, who writes about reproductive rights, outlines the alternative healthcare methods that many are ...

In the second phase of CATALYST, individuals who had abnormal cortisol suppression were offered the opportunity to take part in a randomized trial of mifepristone, a medication that reduces the ...

On the three-year anniversary of the U.S. Supreme Court overturning Roe v Wade, dozens of state lawmakers and prolife groups ...